InvestorsHub Logo
icon url

Timetravelerdos

01/03/20 1:17 PM

#29 RE: masslanding #28

AWESOME Thanks Mass !

Oncolytics Biotech (NASDAQ:ONCY) had its price objective hoisted by Roth Capital from $6.80 to $9.00 in a report issued on Thursday, The Fly reports. They currently have a buy rating on the stock.